Difficulty: Medium
Average Score: 77%
Practice
One of the unfavorable prognostic factors in acute lymphoblastic leukemia is:
Correct answer
B
Rationale
The correct answer is B) T-ALL by immunophenotyping. In pediatric acute lymphoblastic leukemia (ALL), T-cell ALL (T-ALL) is considered an unfavorable prognostic factor due to its aggressive nature and poorer response to treatment compared to B-cell ALL. T-ALL is associated with a higher risk of relapse and lower overall survival rates.
Option A) Age <10 years old is actually a favorable prognostic factor in pediatric ALL, as younger age is associated with better outcomes and response to therapy. Option C) Initial WBCs <50,000/mm┬│ is also a favorable prognostic factor, as lower white blood cell counts at diagnosis are associated with better outcomes. Option D) CSF free from blast cells is important for staging and treatment planning, but it is not a prognostic factor for ALL.
In an educational context, understanding prognostic factors in pediatric ALL is crucial for nurses caring for pediatric oncology patients. Recognizing these factors helps in anticipating patient outcomes, guiding treatment decisions, and providing appropriate support to patients and families throughout the challenging treatment process. Nurses play a significant role in monitoring for signs of relapse, managing treatment side effects, and promoting adherence to therapy in pediatric ALL patients.
Option A) Age <10 years old is actually a favorable prognostic factor in pediatric ALL, as younger age is associated with better outcomes and response to therapy. Option C) Initial WBCs <50,000/mm┬│ is also a favorable prognostic factor, as lower white blood cell counts at diagnosis are associated with better outcomes. Option D) CSF free from blast cells is important for staging and treatment planning, but it is not a prognostic factor for ALL.
In an educational context, understanding prognostic factors in pediatric ALL is crucial for nurses caring for pediatric oncology patients. Recognizing these factors helps in anticipating patient outcomes, guiding treatment decisions, and providing appropriate support to patients and families throughout the challenging treatment process. Nurses play a significant role in monitoring for signs of relapse, managing treatment side effects, and promoting adherence to therapy in pediatric ALL patients.